Transcriptomics technologies

Short description: Study of RNA transcripts

Transcriptomics technologies are the techniques used to study an organism's transcriptome, the sum of all of its RNA transcripts. The information content of an organism is recorded in the DNA of its genome and expressed through transcription. Here, mRNA serves as a transient intermediary molecule in the information network, whilst non-coding RNAs perform additional diverse functions. A transcriptome captures a snapshot in time of the total transcripts present in a cell. Transcriptomics technologies provide a broad account of which cellular processes are active and which are dormant. A major challenge in molecular biology is to understand how a single genome gives rise to a variety of cells. Another is how gene expression is regulated.

The first attempts to study whole transcriptomes began in the early 1990s. Subsequent technological advances since the late 1990s have repeatedly transformed the field and made transcriptomics a widespread discipline in biological sciences. There are two key contemporary techniques in the field: microarrays, which quantify a set of predetermined sequences, and RNA-Seq, which uses high-throughput sequencing to record all transcripts. As the technology improved, the volume of data produced by each transcriptome experiment increased. As a result, data analysis methods have steadily been adapted to more accurately and efficiently analyse increasingly large volumes of data. Transcriptome databases getting bigger and more useful as transcriptomes continue to be collected and shared by researchers. It would be almost impossible to interpret the information contained in a transcriptome without the knowledge of previous experiments.

Measuring the expression of an organism's genes in different tissues or conditions, or at different times, gives information on how genes are regulated and reveals details of an organism's biology. It can also be used to infer the functions of previously unannotated genes. Transcriptome analysis has enabled the study of how gene expression changes in different organisms and has been instrumental in the understanding of human disease. An analysis of gene expression in its entirety allows detection of broad coordinated trends which cannot be discerned by more targeted assays.

## Contents

* 1 History
* 1.1 Before transcriptomics
* 1.2 Early attempts
* 1.3 Development of contemporary techniques
* 2 Data gathering
* 2.1 Isolation of RNA
* 2.2 Expressed sequence tags
* 2.3 Serial and cap analysis of gene expression (SAGE/CAGE)
* 2.4 Microarrays
* 2.4.1 Principles and advances
* 2.4.2 Methods
* 2.5 RNA-Seq
* 2.5.1 Principles and advances
* 2.5.2 Methods
* 3 Data analysis
* 3.1 Image processing
* 3.2 RNA-Seq data analysis
* 3.2.1 Quality control
* 3.2.2 Alignment
* 3.2.3 Quantification
* 3.2.4 Differential expression
* 3.3 Validation
* 4 Applications
* 4.1 Diagnostics and disease profiling
* 4.2 Human and pathogen transcriptomes
* 4.3 Responses to environment
* 4.4 Gene function annotation
* 4.4.1 A transcriptome based aging clock
* 4.5 Non-coding RNA
* 5 Transcriptome databases
* 6 See also
* 7 References
* 7.1 Notes
* 8 Further reading

## History

Transcriptomics method use over time. Published papers referring to RNA-Seq (black), RNA microarray (red), expressed sequence tag (blue), digital differential display (green), and serial/cap analysis of gene expression (yellow) since 1990.[1]

Transcriptomics has been characterised by the development of new techniques which have redefined what is possible every decade or so and rendered previous technologies obsolete. The first attempt at capturing a partial human transcriptome was published in 1991 and reported 609 mRNA sequences from the human brain.[2] In 2008, two human transcriptomes, composed of millions of transcript-derived sequences covering 16,000 genes, were published,[3][4] and by 2015 transcriptomes had been published for hundreds of individuals.[5][6] Transcriptomes of different disease states, tissues, or even single cells are now routinely generated.[6][7][8] This explosion in transcriptomics has been driven by the rapid development of new technologies with improved sensitivity and economy.[9][10][11][12]

### Before transcriptomics

Studies of individual transcripts were being performed several decades before any transcriptomics approaches were available. Libraries of silkmoth mRNA transcripts were collected and converted to complementary DNA (cDNA) for storage using reverse transcriptase in the late 1970s.[13] In the 1980s, low-throughput sequencing using the Sanger method was used to sequence random transcripts, producing expressed sequence tags (ESTs).[2][14][15][16] The Sanger method of sequencing was predominant until the advent of high-throughput methods such as sequencing by synthesis (Solexa/Illumina). ESTs came to prominence during the 1990s as an efficient method to determine the gene content of an organism without sequencing the entire genome.[16] Amounts of individual transcripts were quantified using Northern blotting, nylon membrane arrays, and later reverse transcriptase quantitative PCR (RT-qPCR) methods,[17][18] but these methods are laborious and can only capture a tiny subsection of a transcriptome.[12] Consequently, the manner in which a transcriptome as a whole is expressed and regulated remained unknown until higher-throughput techniques were developed.

### Early attempts

The word "transcriptome" was first used in the 1990s.[19][20] In 1995, one of the earliest sequencing-based transcriptomic methods was developed, serial analysis of gene expression (SAGE), which worked by Sanger sequencing of concatenated random transcript fragments.[21] Transcripts were quantified by matching the fragments to known genes. A variant of SAGE using high-throughput sequencing techniques, called digital gene expression analysis, was also briefly used.[9][22] However, these methods were largely overtaken by high throughput sequencing of entire transcripts, which provided additional information on transcript structure such as splice variants.[9]

### Development of contemporary techniques

Comparison of contemporary methods[23][24][10] | RNA-Seq  | Microarray

|
|

Throughput | 1 day to 1 week per experiment[10] | 1–2 days per experiment[10]
Input RNA amount | Low ~ 1 ng total RNA[25] | High ~ 1 μg mRNA[26]
Labour intensity  | High (sample preparation and data analysis)[10][23] | Low[10][23]
Prior knowledge  | None required, although a reference genome/transcriptome sequence is useful[23] | Reference genome/transcriptome is required for design of probes[23]
Quantitation accuracy  | ~90% (limited by sequence coverage)[27] | >90% (limited by fluorescence detection accuracy)[27]
Sequence resolution  | RNA-Seq can detect SNPs and splice variants (limited by sequencing accuracy of ~99%)[27] | Specialised arrays can detect mRNA splice variants (limited by probe design and cross-hybridisation)[27]
Sensitivity | 1 transcript per million (approximate, limited by sequence coverage)[27] | 1 transcript per thousand (approximate, limited by fluorescence detection)[27]
Dynamic range | 100,000:1 (limited by sequence coverage)[28] | 1,000:1 (limited by fluorescence saturation)[28]
Technical reproducibility | >99%[29][30] | >99%[31][32]

The dominant contemporary techniques, microarrays and RNA-Seq, were developed in the mid-1990s and 2000s.[9][33] Microarrays that measure the abundances of a defined set of transcripts via their hybridisation to an array of complementary probes were first published in 1995.[34][35] Microarray technology allowed the assay of thousands of transcripts simultaneously and at a greatly reduced cost per gene and labour saving.[36] Both spotted oligonucleotide arrays and Affymetrix high-density arrays were the method of choice for transcriptional profiling until the late 2000s.[12][33] Over this period, a range of microarrays were produced to cover known genes in model or economically important organisms. Advances in design and manufacture of arrays improved the specificity of probes and allowed more genes to be tested on a single array. Advances in fluorescence detection increased the sensitivity and measurement accuracy for low abundance transcripts.[35][37]

RNA-Seq is accomplished by reverse transcribing RNA in vitro and sequencing the resulting cDNAs.[10] Transcript abundance is derived from the number of counts from each transcript. The technique has therefore been heavily influenced by the development of high-throughput sequencing technologies.[9][11] Massively parallel signature sequencing (MPSS) was an early example based on generating 16–20 bp sequences via a complex series of hybridisations,[38][note 1] and was used in 2004 to validate the expression of ten thousand genes in Arabidopsis thaliana.[39] The earliest RNA-Seq work was published in 2006 with one hundred thousand transcripts sequenced using 454 technology.[40] This was sufficient coverage to quantify relative transcript abundance. RNA-Seq began to increase in popularity after 2008 when new Solexa/Illumina technologies allowed one billion transcript sequences to be recorded.[4][10][41][42] This yield now allows for the quantification and comparison of human transcriptomes.[43]

## Data gathering

Generating data on RNA transcripts can be achieved via either of two main principles: sequencing of individual transcripts (ESTs, or RNA-Seq) or hybridisation of transcripts to an ordered array of nucleotide probes (microarrays).[23]

### Isolation of RNA

All transcriptomic methods require RNA to first be isolated from the experimental organism before transcripts can be recorded. Although biological systems are incredibly diverse, RNA extraction techniques are broadly similar and involve mechanical disruption of cells or tissues, disruption of RNase with chaotropic salts,[44] disruption of macromolecules and nucleotide complexes, separation of RNA from undesired biomolecules including DNA, and concentration of the RNA via precipitation from solution or elution from a solid matrix.[44][45] Isolated RNA may additionally be treated with DNase to digest any traces of DNA.[46] It is necessary to enrich messenger RNA as total RNA extracts are typically 98% ribosomal RNA.[47] Enrichment for transcripts can be performed by poly-A affinity methods or by depletion of ribosomal RNA using sequence-specific probes.[48] Degraded RNA may affect downstream results; for example, mRNA enrichment from degraded samples will result in the depletion of 5’ mRNA ends and an uneven signal across the length of a transcript. Snap-freezing of tissue prior to RNA isolation is typical, and care is taken to reduce exposure to RNase enzymes once isolation is complete.[45]

### Expressed sequence tags

An expressed sequence tag (EST) is a short nucleotide sequence generated from a single RNA transcript. RNA is first copied as complementary DNA (cDNA) by a reverse transcriptase enzyme before the resultant cDNA is sequenced.[16] Because ESTs can be collected without prior knowledge of the organism from which they come, they can be made from mixtures of organisms or environmental samples.[49][16] Although higher-throughput methods are now used, EST libraries commonly provided sequence information for early microarray designs; for example, a barley microarray was designed from 350,000 previously sequenced ESTs.[50]

### Serial and cap analysis of gene expression (SAGE/CAGE)

Summary of SAGE. Within the organisms, genes are transcribed and spliced (in eukaryotes) to produce mature mRNA transcripts (red). The mRNA is extracted from the organism, and reverse transcriptase is used to copy the mRNA into stable double-stranded–cDNA (ds-cDNA; blue). In SAGE, the ds-cDNA is digested by restriction enzymes (at location ‘X’ and ‘X’+11) to produce 11-nucleotide "tag" fragments. These tags are concatenated and sequenced using long-read Sanger sequencing (different shades of blue indicate tags from different genes). The sequences are deconvoluted to find the frequency of each tag. The tag frequency can be used to report on transcription of the gene that the tag came from.[51]

Serial analysis of gene expression (SAGE) was a development of EST methodology to increase the throughput of the tags generated and allow some quantitation of transcript abundance.[21] cDNA is generated from the RNA but is then digested into 11 bp "tag" fragments using restriction enzymes that cut DNA at a specific sequence, and 11 base pairs along from that sequence. These cDNA tags are then joined head-to-tail into long strands (>500 bp) and sequenced using low-throughput, but long read-length methods such as Sanger sequencing. The sequences are then divided back into their original 11 bp tags using computer software in a process called deconvolution.[21] If a high-quality reference genome is available, these tags may be matched to their corresponding gene in the genome. If a reference genome is unavailable, the tags can be directly used as diagnostic markers if found to be differentially expressed in a disease state.[21]

The cap analysis gene expression (CAGE) method is a variant of SAGE that sequences tags from the 5’ end of an mRNA transcript only.[52] Therefore, the transcriptional start site of genes can be identified when the tags are aligned to a reference genome. Identifying gene start sites is of use for promoter analysis and for the cloning of full-length cDNAs.

SAGE and CAGE methods produce information on more genes than was possible when sequencing single ESTs, but sample preparation and data analysis are typically more labour-intensive.[52]

### Microarrays

Summary of DNA Microarrays. Within the organisms, genes are transcribed and spliced (in eukaryotes) to produce mature mRNA transcripts (red). The mRNA is extracted from the organism and reverse transcriptase is used to copy the mRNA into stable ds-cDNA (blue). In microarrays, the ds-cDNA is fragmented and fluorescently labelled (orange). The labelled fragments bind to an ordered array of complementary oligonucleotides, and measurement of fluorescent intensity across the array indicates the abundance of a predetermined set of sequences. These sequences are typically specifically chosen to report on genes of interest within the organism's genome.[51]

#### Principles and advances

Microarrays usually consist of a grid of short nucleotide oligomers, known as "probes", typically arranged on a glass slide.[53] Transcript abundance is determined by hybridisation of fluorescently labelled transcripts to these probes.[54] The fluorescence intensity at each probe location on the array indicates the transcript abundance for that probe sequence.[54] Groups of probes designed to measure the same transcript (i.e., hybridizing a specific transcript in different positions) are usually referred to as "probesets".

Microarrays require some genomic knowledge from the organism of interest, for example, in the form of an annotated genome sequence, or a library of ESTs that can be used to generate the probes for the array.[36]

#### Methods

Microarrays for transcriptomics typically fall into one of two broad categories: low-density spotted arrays or high-density short probe arrays. Transcript abundance is inferred from the intensity of fluorescence derived from fluorophore-tagged transcripts that bind to the array.[36]

Spotted low-density arrays typically feature picolitre[note 2] drops of a range of purified cDNAs arrayed on the surface of a glass slide.[55] These probes are longer than those of high-density arrays and cannot identify alternative splicing events. Spotted arrays use two different fluorophores to label the test and control samples, and the ratio of fluorescence is used to calculate a relative measure of abundance.[56] High-density arrays use a single fluorescent label, and each sample is hybridised and detected individually.[57] High-density arrays were popularised by the Affymetrix GeneChip array, where each transcript is quantified by several short 25-mer probes that together assay one gene.[58]

NimbleGen arrays were a high-density array produced by a maskless-photochemistry method, which permitted flexible manufacture of arrays in small or large numbers. These arrays had 100,000s of 45 to 85-mer probes and were hybridised with a one-colour labelled sample for expression analysis.[59] Some designs incorporated up to 12 independent arrays per slide.

### RNA-Seq

Summary of RNA-Seq. Within the organisms, genes are transcribed and spliced (in eukaryotes) to produce mature mRNA transcripts (red). The mRNA is extracted from the organism, fragmented, and copied into stable ds-cDNA (blue). The ds-cDNA is sequenced using high-throughput, short-read sequencing methods. These sequences can then be aligned to a reference genome sequence to reconstruct which genome regions were being transcribed. This data can be used to annotate where expressed genes are, their relative expression levels, and any alternative splice variants.[51]

#### Principles and advances

RNA-Seq refers to the combination of a high-throughput sequencing methodology with computational methods to capture and quantify transcripts present in an RNA extract.[10] The nucleotide sequences generated are typically around 100 bp in length, but can range from 30 bp to over 10,000 bp depending on the sequencing method used. RNA-Seq leverages deep sampling of the transcriptome with many short fragments from a transcriptome to allow computational reconstruction of the original RNA transcript by aligning reads to a reference genome or to each other (de novo assembly).[9] Both low-abundance and high-abundance RNAs can be quantified in an RNA-Seq experiment (dynamic range of 5 orders of magnitude)—a key advantage over microarray transcriptomes. In addition, input RNA amounts are much lower for RNA-Seq (nanogram quantity) compared to microarrays (microgram quantity), which allow examination of the transcriptome even at a single-cell resolution when combined with amplification of cDNA.[25][60] Theoretically, there is no upper limit of quantification in RNA-Seq, and background noise is very low for 100 bp reads in non-repetitive regions.[10]

RNA-Seq may be used to identify genes within a genome, or identify which genes are active at a particular point in time, and read counts can be used to accurately model the relative gene expression level. RNA-Seq methodology has constantly improved, primarily through the development of DNA sequencing technologies to increase throughput, accuracy, and read length.[61] Since the first descriptions in 2006 and 2008,[40][62] RNA-Seq has been rapidly adopted and overtook microarrays as the dominant transcriptomics technique in 2015.[63]

The quest for transcriptome data at the level of individual cells has driven advances in RNA-Seq library preparation methods, resulting in dramatic advances in sensitivity. Single-cell transcriptomes are now well described and have even been extended to in situ RNA-Seq where transcriptomes of individual cells are directly interrogated in fixed tissues.[64]

#### Methods

RNA-Seq was established in concert with the rapid development of a range of high-throughput DNA sequencing technologies.[65] However, before the extracted RNA transcripts are sequenced, several key processing steps are performed. Methods differ in the use of transcript enrichment, fragmentation, amplification, single or paired-end sequencing, and whether to preserve strand information.[65]

The sensitivity of an RNA-Seq experiment can be increased by enriching classes of RNA that are of interest and depleting known abundant RNAs. The mRNA molecules can be separated using oligonucleotides probes which bind their poly-A tails. Alternatively, ribo-depletion can be used to specifically remove abundant but uninformative ribosomal RNAs (rRNAs) by hybridisation to probes tailored to the taxon's specific rRNA sequences (e.g. mammal rRNA, plant rRNA). However, ribo-depletion can also introduce some bias via non-specific depletion of off-target transcripts.[66] Small RNAs, such as micro RNAs, can be purified based on their size by gel electrophoresis and extraction.

Since mRNAs are longer than the read-lengths of typical high-throughput sequencing methods, transcripts are usually fragmented prior to sequencing.[67] The fragmentation method is a key aspect of sequencing library construction. Fragmentation may be achieved by chemical hydrolysis, nebulisation, sonication, or reverse transcription with chain-terminating nucleotides.[67] Alternatively, fragmentation and cDNA tagging may be done simultaneously by using transposase enzymes.[68]

During preparation for sequencing, cDNA copies of transcripts may be amplified by PCR to enrich for fragments that contain the expected 5’ and 3’ adapter sequences.[69] Amplification is also used to allow sequencing of very low input amounts of RNA, down to as little as 50 pg in extreme applications.[70] Spike-in controls of known RNAs can be used for quality control assessment to check library preparation and sequencing, in terms of GC-content, fragment length, as well as the bias due to fragment position within a transcript.[71] Unique molecular identifiers (UMIs) are short random sequences that are used to individually tag sequence fragments during library preparation so that every tagged fragment is unique.[72] UMIs provide an absolute scale for quantification, the opportunity to correct for subsequent amplification bias introduced during library construction, and accurately estimate the initial sample size. UMIs are particularly well-suited to single-cell RNA-Seq transcriptomics, where the amount of input RNA is restricted and extended amplification of the sample is required.[73][74][75]

Once the transcript molecules have been prepared they can be sequenced in just one direction (single-end) or both directions (paired-end). A single-end sequence is usually quicker to produce, cheaper than paired-end sequencing and sufficient for quantification of gene expression levels. Paired-end sequencing produces more robust alignments/assemblies, which is beneficial for gene annotation and transcript isoform discovery.[10] Strand-specific RNA-Seq methods preserve the strand information of a sequenced transcript.[76] Without strand information, reads can be aligned to a gene locus but do not inform in which direction the gene is transcribed. Stranded-RNA-Seq is useful for deciphering transcription for genes that overlap in different directions and to make more robust gene predictions in non-model organisms.[76]

Sequencing technology platforms commonly used for RNA-Seq[77][78] Platform  | Commercial release  | Typical read length  | Maximum throughput per run  | Single read accuracy  | RNA-Seq runs deposited in the NCBI SRA (Oct 2016)[79]

|
|
|
|
|

454 Life Sciences | 2005  | 700 bp  | 0.7 Gbp  | 99.9%  | 3548
Illumina | 2006  | 50–300 bp  | 900 Gbp  | 99.9%  | 362903
SOLiD | 2008  | 50 bp  | 320 Gbp  | 99.9%  | 7032
Ion Torrent | 2010  | 400 bp  | 30 Gbp  | 98%  | 1953
PacBio | 2011  | 10,000 bp  | 2 Gbp  | 87%  | 160

Legend: NCBI SRA – National center for biotechnology information sequence read archive.

Currently RNA-Seq relies on copying RNA molecules into cDNA molecules prior to sequencing; therefore, the subsequent platforms are the same for transcriptomic and genomic data. Consequently, the development of DNA sequencing technologies has been a defining feature of RNA-Seq.[78][80][81] Direct sequencing of RNA using nanopore sequencing represents a current state-of-the-art RNA-Seq technique.[82][83] Nanopore sequencing of RNA can detect modified bases that would be otherwise masked when sequencing cDNA and also eliminates amplification steps that can otherwise introduce bias.[11][84]

The sensitivity and accuracy of an RNA-Seq experiment are dependent on the number of reads obtained from each sample.[85][86] A large number of reads are needed to ensure sufficient coverage of the transcriptome, enabling detection of low abundance transcripts. Experimental design is further complicated by sequencing technologies with a limited output range, the variable efficiency of sequence creation, and variable sequence quality. Added to those considerations is that every species has a different number of genes and therefore requires a tailored sequence yield for an effective transcriptome. Early studies determined suitable thresholds empirically, but as the technology matured suitable coverage was predicted computationally by transcriptome saturation. Somewhat counter-intuitively, the most effective way to improve detection of differential expression in low expression genes is to add more biological replicates rather than adding more reads.[87] The current benchmarks recommended by the Encyclopedia of DNA Elements (ENCODE) Project are for 70-fold exome coverage for standard RNA-Seq and up to 500-fold exome coverage to detect rare transcripts and isoforms.[88][89][90]

## Data analysis

Transcriptomics methods are highly parallel and require significant computation to produce meaningful data for both microarray and RNA-Seq experiments.[91][92][93][94][95] Microarray data is recorded as high-resolution images, requiring feature detection and spectral analysis.[96] Microarray raw image files are each about 750 MB in size, while the processed intensities are around 60 MB in size. Multiple short probes matching a single transcript can reveal details about the intron-exon structure, requiring statistical models to determine the authenticity of the resulting signal. RNA-Seq studies produce billions of short DNA sequences, which must be aligned to reference genomes composed of millions to billions of base pairs. De novo assembly of reads within a dataset requires the construction of highly complex sequence graphs.[97] RNA-Seq operations are highly repetitious and benefit from parallelised computation but modern algorithms mean consumer computing hardware is sufficient for simple transcriptomics experiments that do not require de novo assembly of reads.[98] A human transcriptome could be accurately captured using RNA-Seq with 30 million 100 bp sequences per sample.[85][86] This example would require approximately 1.8 gigabytes of disk space per sample when stored in a compressed fastq format. Processed count data for each gene would be much smaller, equivalent to processed microarray intensities. Sequence data may be stored in public repositories, such as the Sequence Read Archive (SRA).[99] RNA-Seq datasets can be uploaded via the Gene Expression Omnibus.[100]

### Image processing

Microarray and sequencing flow cell. Microarrays and RNA-seq rely on image analysis in different ways. In a microarray chip, each spot on a chip is a defined oligonucleotide probe, and fluorescence intensity directly detects the abundance of a specific sequence (Affymetrix). In a high-throughput sequencing flow cell, spots are sequenced one nucleotide at a time, with the colour at each round indicating the next nucleotide in the sequence (Illumina Hiseq). Other variations of these techniques use more or fewer colour channels.[51][101]

Microarray image processing must correctly identify the regular grid of features within an image and independently quantify the fluorescence intensity for each feature. Image artefacts must be additionally identified and removed from the overall analysis. Fluorescence intensities directly indicate the abundance of each sequence, since the sequence of each probe on the array is already known.[102]

The first steps of RNA-seq also include similar image processing; however, conversion of images to sequence data is typically handled automatically by the instrument software. The Illumina sequencing-by-synthesis method results in an array of clusters distributed over the surface of a flow cell.[103] The flow cell is imaged up to four times during each sequencing cycle, with tens to hundreds of cycles in total. Flow cell clusters are analogous to microarray spots and must be correctly identified during the early stages of the sequencing process. In Roche’s pyrosequencing method, the intensity of emitted light determines the number of consecutive nucleotides in a homopolymer repeat. There are many variants on these methods, each with a different error profile for the resulting data.[104]

### RNA-Seq data analysis

RNA-Seq experiments generate a large volume of raw sequence reads which have to be processed to yield useful information. Data analysis usually requires a combination of bioinformatics software tools (see also List of RNA-Seq bioinformatics tools) that vary according to the experimental design and goals. The process can be broken down into four stages: quality control, alignment, quantification, and differential expression.[105] Most popular RNA-Seq programs are run from a command-line interface, either in a Unix environment or within the R/Bioconductor statistical environment.[94]

#### Quality control

Sequence reads are not perfect, so the accuracy of each base in the sequence needs to be estimated for downstream analyses. Raw data is examined to ensure: quality scores for base calls are high, the GC content matches the expected distribution, short sequence motifs (k-mers) are not over-represented, and the read duplication rate is acceptably low.[86] Several software options exist for sequence quality analysis, including FastQC and FaQCs.[106][107] Abnormalities may be removed (trimming) or tagged for special treatment during later processes.

#### Alignment

In order to link sequence read abundance to the expression of a particular gene, transcript sequences are aligned to a reference genome or de novo aligned to one another if no reference is available.[108][109][110] The key challenges for alignment software include sufficient speed to permit billions of short sequences to be aligned in a meaningful timeframe, flexibility to recognise and deal with intron splicing of eukaryotic mRNA, and correct assignment of reads that map to multiple locations. Software advances have greatly addressed these issues, and increases in sequencing read length reduce the chance of ambiguous read alignments. A list of currently available high-throughput sequence aligners is maintained by the EBI.[111][112]

Alignment of primary transcript mRNA sequences derived from eukaryotes to a reference genome requires specialised handling of intron sequences, which are absent from mature mRNA.[113] Short read aligners perform an additional round of alignments specifically designed to identify splice junctions, informed by canonical splice site sequences and known intron splice site information. Identification of intron splice junctions prevents reads from being misaligned across splice junctions or erroneously discarded, allowing more reads to be aligned to the reference genome and improving the accuracy of gene expression estimates. Since gene regulation may occur at the mRNA isoform level, splice-aware alignments also permit detection of isoform abundance changes that would otherwise be lost in a bulked analysis.[114]

De novo assembly can be used to align reads to one another to construct full-length transcript sequences without use of a reference genome.[115] Challenges particular to de novo assembly include larger computational requirements compared to a reference-based transcriptome, additional validation of gene variants or fragments, and additional annotation of assembled transcripts. The first metrics used to describe transcriptome assemblies, such as N50, have been shown to be misleading[116] and improved evaluation methods are now available.[117][118] Annotation-based metrics are better assessments of assembly completeness, such as contig reciprocal best hit count. Once assembled de novo, the assembly can be used as a reference for subsequent sequence alignment methods and quantitative gene expression analysis.

RNA-Seq de novo assembly software Software | Released | Last updated | Computational efficiency | Strengths and weaknesses

|
|
|
|

Velvet-Oases[119][120] | 2008  | 2011  | Low, single-threaded, high RAM requirement  | The original short read assembler. It is now largely superseded.
SOAPdenovo-trans[109] | 2011  | 2014  | Moderate, multi-thread, medium RAM requirement  | An early example of a short read assembler. It has been updated for transcriptome assembly.
Trans-ABySS[121] | 2010  | 2016  | Moderate, multi-thread, medium RAM requirement  | Suited to short reads, can handle complex transcriptomes, and an MPI-parallel version is available for computing clusters.
Trinity[122][97] | 2011  | 2017  | Moderate, multi-thread, medium RAM requirement  | Suited to short reads. It can handle complex transcriptomes but is memory intensive.
miraEST[123] | 1999  | 2016  | Moderate, multi-thread, medium RAM requirement  | Can process repetitive sequences, combine different sequencing formats, and a wide range of sequence platforms are accepted.
Newbler[124] | 2004  | 2012  | Low, single-thread, high RAM requirement  | Specialised to accommodate the homo-polymer sequencing errors typical of Roche 454 sequencers.
CLC genomics workbench[125] | 2008  | 2014  | High, multi-thread, low RAM requirement  | Has a graphical user interface, can combine diverse sequencing technologies, has no transcriptome-specific features, and a licence must be purchased before use.
SPAdes[126] | 2012  | 2017  | High, multi-thread, low RAM requirement  | Used for transcriptomics experiments on single cells.
RSEM[127] | 2011  | 2017  | High, multi-thread, low RAM requirement  | Can estimate frequency of alternatively spliced transcripts. User friendly.
StringTie[98][128] | 2015  | 2019  | High, multi-thread, low RAM requirement  | Can use a combination of reference-guided and de novo assembly methods to identify transcripts.

Legend: RAM – random access memory; MPI – message passing interface; EST – expressed sequence tag.

#### Quantification

Heatmap identification of gene co-expression patterns across different samples. Each column contains the measurements for gene expression change for a single sample. Relative gene expression is indicated by colour: high-expression (red), median-expression (white) and low-expression (blue). Genes and samples with similar expression profiles can be automatically grouped (left and top trees). Samples may be different individuals, tissues, environments or health conditions. In this example, expression of gene set 1 is high and expression of gene set 2 is low in samples 1, 2, and 3.[51][129]

Quantification of sequence alignments may be performed at the gene, exon, or transcript level.[91][87] Typical outputs include a table of read counts for each feature supplied to the software; for example, for genes in a general feature format file. Gene and exon read counts may be calculated quite easily using HTSeq, for example.[130] Quantitation at the transcript level is more complicated and requires probabilistic methods to estimate transcript isoform abundance from short read information; for example, using cufflinks software.[114] Reads that align equally well to multiple locations must be identified and either removed, aligned to one of the possible locations, or aligned to the most probable location.

Some quantification methods can circumvent the need for an exact alignment of a read to a reference sequence altogether. The kallisto software method combines pseudoalignment and quantification into a single step that runs 2 orders of magnitude faster than contemporary methods such as those used by tophat/cufflinks software, with less computational burden.[131]

#### Differential expression

Once quantitative counts of each transcript are available, differential gene expression is measured by normalising, modelling, and statistically analysing the data.[108] Most tools will read a table of genes and read counts as their input, but some programs, such as cuffdiff, will accept binary alignment map format read alignments as input. The final outputs of these analyses are gene lists with associated pair-wise tests for differential expression between treatments and the probability estimates of those differences.[132]

RNA-Seq differential gene expression software Software  | Environment  | Specialisation

|
|

Cuffdiff2[108] | Unix-based  | Transcript analysis that tracks alternative splicing of mRNA
EdgeR[93] | R/Bioconductor  | Any count-based genomic data
DEseq2[133] | R/Bioconductor  | Flexible data types, low replication
Limma/Voom[92] | R/Bioconductor  | Microarray or RNA-Seq data, flexible experiment design
Ballgown[134] | R/Bioconductor  | Efficient and sensitive transcript discovery, flexible.

Legend: mRNA - messenger RNA.

### Validation

Transcriptomic analyses may be validated using an independent technique, for example, quantitative PCR (qPCR), which is recognisable and statistically assessable.[135] Gene expression is measured against defined standards both for the gene of interest and control genes. The measurement by qPCR is similar to that obtained by RNA-Seq wherein a value can be calculated for the concentration of a target region in a given sample. qPCR is, however, restricted to amplicons smaller than 300 bp, usually toward the 3’ end of the coding region, avoiding the 3’UTR.[136] If validation of transcript isoforms is required, an inspection of RNA-Seq read alignments should indicate where qPCR primers might be placed for maximum discrimination. The measurement of multiple control genes along with the genes of interest produces a stable reference within a biological context.[137] qPCR validation of RNA-Seq data has generally shown that different RNA-Seq methods are highly correlated.[62][138][139]

Functional validation of key genes is an important consideration for post transcriptome planning. Observed gene expression patterns may be functionally linked to a phenotype by an independent knock-down/rescue study in the organism of interest.[140]

## Applications

### Diagnostics and disease profiling

Transcriptomic strategies have seen broad application across diverse areas of biomedical research, including disease diagnosis and profiling.[10][141] RNA-Seq approaches have allowed for the large-scale identification of transcriptional start sites, uncovered alternative promoter usage, and novel splicing alterations. These regulatory elements are important in human disease and, therefore, defining such variants is crucial to the interpretation of disease-association studies.[142] RNA-Seq can also identify disease-associated single nucleotide polymorphisms (SNPs), allele-specific expression, and gene fusions, which contributes to the understanding of disease causal variants.[143]

Retrotransposons are transposable elements which proliferate within eukaryotic genomes through a process involving reverse transcription. RNA-Seq can provide information about the transcription of endogenous retrotransposons that may influence the transcription of neighboring genes by various epigenetic mechanisms that lead to disease.[144] Similarly, the potential for using RNA-Seq to understand immune-related disease is expanding rapidly due to the ability to dissect immune cell populations and to sequence T cell and B cell receptor repertoires from patients.[145][146]

### Human and pathogen transcriptomes

RNA-Seq of human pathogens has become an established method for quantifying gene expression changes, identifying novel virulence factors, predicting antibiotic resistance, and unveiling host-pathogen immune interactions.[147][148] A primary aim of this technology is to develop optimised infection control measures and targeted individualised treatment.[146]

Transcriptomic analysis has predominantly focused on either the host or the pathogen. Dual RNA-Seq has been applied to simultaneously profile RNA expression in both the pathogen and host throughout the infection process. This technique enables the study of the dynamic response and interspecies gene regulatory networks in both interaction partners from initial contact through to invasion and the final persistence of the pathogen or clearance by the host immune system.[149][150]

### Responses to environment

Transcriptomics allows identification of genes and pathways that respond to and counteract biotic and abiotic environmental stresses.[151][140] The non-targeted nature of transcriptomics allows the identification of novel transcriptional networks in complex systems. For example, comparative analysis of a range of chickpea lines at different developmental stages identified distinct transcriptional profiles associated with drought and salinity stresses, including identifying the role of transcript isoforms of AP2-EREBP.[151] Investigation of gene expression during biofilm formation by the fungal pathogen Candida albicans revealed a co-regulated set of genes critical for biofilm establishment and maintenance.[152]

Transcriptomic profiling also provides crucial information on mechanisms of drug resistance. Analysis of over 1000 isolates of Plasmodium falciparum, a virulent parasite responsible for malaria in humans,[153] identified that upregulation of the unfolded protein response and slower progression through the early stages of the asexual intraerythrocytic developmental cycle were associated with artemisinin resistance in isolates from Southeast Asia.[154]

The use of transcriptomics is also important to investigate responses in the marine environment.[155] In marine ecology, "stress" and "adaptation" have been among the most common research topics, especially related to anthropogenic stress, such as global change and pollution.[155] Most of the studies in this area have been done in animals, although invertebrates have been underrepresented.[155] One issue still is a deficiency in functional genetic studies, which hamper gene annotations, especially for non-model species, and can lead to vague conclusions on the effects of responses studied.[155]

### Gene function annotation

All transcriptomic techniques have been particularly useful in identifying the functions of genes and identifying those responsible for particular phenotypes. Transcriptomics of Arabidopsis ecotypes that hyperaccumulate metals correlated genes involved in metal uptake, tolerance, and homeostasis with the phenotype.[156] Integration of RNA-Seq datasets across different tissues has been used to improve annotation of gene functions in commercially important organisms (e.g. cucumber)[157] or threatened species (e.g. koala).[158]

Assembly of RNA-Seq reads is not dependent on a reference genome[122] and so is ideal for gene expression studies of non-model organisms with non-existing or poorly developed genomic resources. For example, a database of SNPs used in Douglas fir breeding programs was created by de novo transcriptome analysis in the absence of a sequenced genome.[159] Similarly, genes that function in the development of cardiac, muscle, and nervous tissue in lobsters were identified by comparing the transcriptomes of the various tissue types without use of a genome sequence.[160] RNA-Seq can also be used to identify previously unknown protein coding regions in existing sequenced genomes.

#### A transcriptome based aging clock

Aging-related preventive interventions are not possible without personal aging speed measurement. The most up to date and complex way to measure aging rate is by using varying biomarkers of human aging is based on the utilization of deep neural networks which may be trained on any type of omics biological data to predict the subject's age. Aging has been shown to be a strong driver of transcriptome changes.[161][162] Aging clocks based on transcriptomes have suffered from considerable variation in the data and relatively low accuracy. However an approach that uses temporal scaling and binarization of transcriptomes to define a gene set that predicts biological age with an accuracy allowed to reach an assessment close to the theoretical limit.[161]

### Non-coding RNA

Transcriptomics is most commonly applied to the mRNA content of the cell. However, the same techniques are equally applicable to non-coding RNAs (ncRNAs) that are not translated into a protein, but instead have direct functions (e.g. roles in protein translation, DNA replication, RNA splicing, and transcriptional regulation).[163][164][165][166] Many of these ncRNAs affect disease states, including cancer, cardiovascular, and neurological diseases.[167]

## Transcriptome databases

Transcriptomics studies generate large amounts of data that have potential applications far beyond the original aims of an experiment. As such, raw or processed data may be deposited in public databases to ensure their utility for the broader scientific community. For example, as of 2018, the Gene Expression Omnibus contained millions of experiments.[168]

Transcriptomic databases  Name  | Host  | Data  | Description

|
|
|

Gene Expression Omnibus[100] | NCBI | Microarray RNA-Seq  | First transcriptomics database to accept data from any source. Introduced MIAME and MINSEQE community standards that define necessary experiment metadata to ensure effective interpretation and repeatability.[169][170]
ArrayExpress[171] | ENA | Microarray  | Imports datasets from the Gene Expression Omnibus and accepts direct submissions. Processed data and experiment metadata is stored at ArrayExpress, while the raw sequence reads are held at the ENA. Complies with MIAME and MINSEQE standards.[169][170]
Expression Atlas[172] | EBI | Microarray RNA-Seq  | Tissue-specific gene expression database for animals and plants. Displays secondary analyses and visualisation, such as functional enrichment of Gene Ontology terms, InterPro domains, or pathways. Links to protein abundance data where available.
Genevestigator[173] | Privately curated  | Microarray RNA-Seq  | Contains manual curations of public transcriptome datasets, focusing on medical and plant biology data. Individual experiments are normalised across the full database to allow comparison of gene expression across diverse experiments. Full functionality requires licence purchase, with free access to a limited functionality.
RefEx[174] | DDBJ | All  | Human, mouse, and rat transcriptomes from 40 different organs. Gene expression visualised as heatmaps projected onto 3D representations of anatomical structures.
NONCODE[175] | noncode.org  | RNA-Seq  | Non-coding RNAs (ncRNAs) excluding tRNA and rRNA.

Legend: NCBI – National Center for Biotechnology Information; EBI – European Bioinformatics Institute; DDBJ – DNA Data Bank of Japan; ENA – European Nucleotide Archive; MIAME – Minimum Information About a Microarray Experiment; MINSEQE – Minimum Information about a high-throughput nucleotide SEQuencing Experiment.

## See also

* omics
* Genomics
* Proteomics
* Metabolomics
* Venomics

## References

1. ↑ "Medline trend: automated yearly statistics of PubMed results for any query". http://dan.corlan.net/medline-trend.html.
2. ↑ 2.0 2.1 "Complementary DNA sequencing: expressed sequence tags and human genome project". Science 252 (5013): 1651–6. June 1991. doi:10.1126/science.2047873. PMID 2047873. Bibcode: 1991Sci...252.1651A.
3. ↑ "Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing". Nature Genetics 40 (12): 1413–5. December 2008. doi:10.1038/ng.259. PMID 18978789.
4. ↑ 4.0 4.1 "A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome". Science 321 (5891): 956–60. August 2008. doi:10.1126/science.1160342. PMID 18599741. Bibcode: 2008Sci...321..956S.
5. ↑ "Transcriptome and genome sequencing uncovers functional variation in humans". Nature 501 (7468): 506–11. September 2013. doi:10.1038/nature12531. PMID 24037378. Bibcode: 2013Natur.501..506L.
6. ↑ 6.0 6.1 "Human genomics. The human transcriptome across tissues and individuals". Science 348 (6235): 660–5. May 2015. doi:10.1126/science.aaa0355. PMID 25954002. Bibcode: 2015Sci...348..660M.
7. ↑ "Entering the era of single-cell transcriptomics in biology and medicine". Nature Methods 11 (1): 22–4. January 2014. doi:10.1038/nmeth.2764. PMID 24524133. https://zenodo.org/record/890299.
8. ↑ "The technology and biology of single-cell RNA sequencing". Molecular Cell 58 (4): 610–20. May 2015. doi:10.1016/j.molcel.2015.04.005. PMID 26000846.
9. ↑ 9.0 9.1 9.2 9.3 9.4 9.5 "Transcriptomics in the RNA-seq era". Current Opinion in Chemical Biology 17 (1): 4–11. February 2013. doi:10.1016/j.cbpa.2012.12.008. PMID 23290152.
10. ↑ 10.00 10.01 10.02 10.03 10.04 10.05 10.06 10.07 10.08 10.09 10.10 10.11 "RNA-Seq: a revolutionary tool for transcriptomics". Nature Reviews Genetics 10 (1): 57–63. January 2009. doi:10.1038/nrg2484. PMID 19015660.
11. ↑ 11.0 11.1 11.2 "RNA sequencing: advances, challenges and opportunities". Nature Reviews Genetics 12 (2): 87–98. February 2011. doi:10.1038/nrg2934. PMID 21191423.
12. ↑ 12.0 12.1 12.2 "Applications of new sequencing technologies for transcriptome analysis". Annual Review of Genomics and Human Genetics 10: 135–51. 2009. doi:10.1146/annurev-genom-082908-145957. PMID 19715439.
13. ↑ "Use of a cDNA library for studies on evolution and developmental expression of the chorion multigene families". Cell 18 (4): 1303–16. December 1979. doi:10.1016/0092-8674(79)90241-1. PMID 519770.
14. ↑ "Common 82-nucleotide sequence unique to brain RNA". Proceedings of the National Academy of Sciences of the United States of America 79 (16): 4942–6. August 1982. doi:10.1073/pnas.79.16.4942. PMID 6956902. Bibcode: 1982PNAS...79.4942S.
15. ↑ "A new troponin T and cDNA clones for 13 different muscle proteins, found by shotgun sequencing". Nature 302 (5910): 718–21. April 1983. doi:10.1038/302718a0. PMID 6687628. Bibcode: 1983Natur.302..718P.
16. ↑ 16.0 16.1 16.2 16.3 "Expressed sequence tags—ESTablishing bridges between genomes". Trends in Genetics 14 (1): 4–7. January 1998. doi:10.1016/S0168-9525(97)01355-3. PMID 9448457.
17. ↑ "Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes". Proceedings of the National Academy of Sciences of the United States of America 74 (12): 5350–4. December 1977. doi:10.1073/pnas.74.12.5350. PMID 414220. Bibcode: 1977PNAS...74.5350A.
18. ↑ "Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY)". Nucleic Acids Research 17 (22): 9437–46. November 1989. doi:10.1093/nar/17.22.9437. PMID 2479917.
19. ↑ "The Genexpress IMAGE knowledge base of the human brain transcriptome: a prototype integrated resource for functional and computational genomics". Genome Research 9 (2): 195–209. February 1999. doi:10.1101/gr.9.2.195. PMID 10022985.
20. ↑ "Characterization of the yeast transcriptome". Cell 88 (2): 243–51. January 1997. doi:10.1016/S0092-8674(00)81845-0. PMID 9008165.
21. ↑ 21.0 21.1 21.2 21.3 "Serial analysis of gene expression". Science 270 (5235): 484–7. October 1995. doi:10.1126/science.270.5235.484. PMID 7570003. Bibcode: 1995Sci...270..484V.
22. ↑ "The significance of digital gene expression profiles". Genome Research 7 (10): 986–95. October 1997. doi:10.1101/gr.7.10.986. PMID 9331369.
23. ↑ 23.0 23.1 23.2 23.3 23.4 23.5 "Comparing bioinformatic gene expression profiling methods: microarray and RNA-Seq". Medical Science Monitor Basic Research 20: 138–42. August 2014. doi:10.12659/MSMBR.892101. PMID 25149683.
24. ↑ "Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells". PLOS ONE 9 (1): e78644. 2014. doi:10.1371/journal.pone.0078644. PMID 24454679. Bibcode: 2014PLoSO...978644Z.
25. ↑ 25.0 25.1 "CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification". Cell Reports 2 (3): 666–73. September 2012. doi:10.1016/j.celrep.2012.08.003. PMID 22939981.
26. ↑ "A novel, sensitive detection system for high-density microarrays using dendrimer technology". Physiological Genomics 3 (2): 93–9. August 2000. doi:10.1152/physiolgenomics.2000.3.2.93. PMID 11015604.
27. ↑ 27.0 27.1 27.2 27.3 27.4 27.5 Illumina (2011-07-11). "RNA-Seq Data Comparison with Gene Expression Microarrays". European Pharmaceutical Review. http://www.europeanpharmaceuticalreview.com/wp-content/uploads/Illumina_whitepaper.pdf.
28. ↑ 28.0 28.1 "Comparison of microarrays and RNA-seq for gene expression analyses of dose-response experiments". Toxicological Sciences 137 (2): 385–403. February 2014. doi:10.1093/toxsci/kft249. PMID 24194394.
29. ↑ "RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays". Genome Research 18 (9): 1509–17. September 2008. doi:10.1101/gr.079558.108. PMID 18550803.
30. ↑ SEQC/MAQC-III Consortium (September 2014). "A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium". Nature Biotechnology 32 (9): 903–14. doi:10.1038/nbt.2957. PMID 25150838.
31. ↑ "Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data". BMC Bioinformatics 8: 412. October 2007. doi:10.1186/1471-2105-8-412. PMID 17961233.
32. ↑ "Independence and reproducibility across microarray platforms". Nature Methods 2 (5): 337–44. May 2005. doi:10.1038/nmeth757. PMID 15846360.
33. ↑ 33.0 33.1 "Microarrays have arrived: gene expression tool matures". Journal of the National Cancer Institute 93 (7): 492–4. April 2001. doi:10.1093/jnci/93.7.492. PMID 11287436.
34. ↑ "Quantitative monitoring of gene expression patterns with a complementary DNA microarray". Science 270 (5235): 467–70. October 1995. doi:10.1126/science.270.5235.467. PMID 7569999. Bibcode: 1995Sci...270..467S.
35. ↑ 35.0 35.1 "Oligonucleotide microarrays: widely applied—poorly understood". Briefings in Functional Genomics & Proteomics 6 (2): 141–8. June 2007. doi:10.1093/bfgp/elm014. PMID 17644526. http://edoc.mpg.de/get.epl?fid=85687&did=572223&ver=0.
36. ↑ 36.0 36.1 36.2 "DNA microarray technology: devices, systems, and applications". Annual Review of Biomedical Engineering 4: 129–53. 2002. doi:10.1146/annurev.bioeng.4.020702.153438. PMID 12117754.
37. ↑ McLachlan, Geoffrey J.; Do, Kim-Anh; Ambroise, Christopher (2005). Analyzing Microarray Gene Expression Data. Hoboken: John Wiley & Sons. ISBN 978-0-471-72612-8. [page needed]
38. ↑ "Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays". Nature Biotechnology 18 (6): 630–4. June 2000. doi:10.1038/76469. PMID 10835600.
39. ↑ "Analysis of the transcriptional complexity of Arabidopsis thaliana by massively parallel signature sequencing". Nature Biotechnology 22 (8): 1006–11. August 2004. doi:10.1038/nbt992. PMID 15247925.
40. ↑ 40.0 40.1 "Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach". BMC Genomics 7: 246. September 2006. doi:10.1186/1471-2164-7-246. PMID 17010196.
41. ↑ "Mapping and quantifying mammalian transcriptomes by RNA-Seq". Nature Methods 5 (7): 621–8. July 2008. doi:10.1038/nmeth.1226. PMID 18516045.
42. ↑ "Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution". Nature 453 (7199): 1239–43. June 2008. doi:10.1038/nature07002. PMID 18488015. Bibcode: 2008Natur.453.1239W.
43. ↑ "A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome". Science 321 (5891): 956–60. August 2008. doi:10.1126/science.1160342. PMID 18599741. Bibcode: 2008Sci...321..956S.
44. ↑ 44.0 44.1 "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction". Analytical Biochemistry 162 (1): 156–9. April 1987. doi:10.1016/0003-2697(87)90021-2. PMID 2440339.
45. ↑ 45.0 45.1 "The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on". Nature Protocols 1 (2): 581–5. 2006. doi:10.1038/nprot.2006.83. PMID 17406285.
46. ↑ "Use of reverse transcriptase polymerase chain reaction to monitor expression of intronless genes". BioTechniques 9 (3): 262, 264, 266–8. September 1990. PMID 1699561.
47. ↑ "Isolation of messenger RNA". RNA Isolation and Characterization Protocols. Methods in Molecular Biology. 86. 1998. pp. 61–4. doi:10.1385/0-89603-494-1:61. ISBN 978-0-89603-494-5.
48. ↑ "Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling". BMC Genomics 15 (1): 419. June 2014. doi:10.1186/1471-2164-15-419. PMID 24888378.
49. ↑ Some examples of environmental samples include: sea water, soil, or air.
50. ↑ "A new resource for cereal genomics: 22K barley GeneChip comes of age". Plant Physiology 134 (3): 960–8. March 2004. doi:10.1104/pp.103.034462. PMID 15020760.
51. ↑ 51.0 51.1 51.2 51.3 51.4 "Transcriptomics technologies". PLOS Computational Biology 13 (5): e1005457. May 2017. doi:10.1371/journal.pcbi.1005457. PMID 28545146. Bibcode: 2017PLSCB..13E5457L.
52. ↑ 52.0 52.1 "Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage". Proceedings of the National Academy of Sciences of the United States of America 100 (26): 15776–81. December 2003. doi:10.1073/pnas.2136655100. PMID 14663149. Bibcode: 2003PNAS..10015776S.
53. ↑ "A critical comparison of protein microarray fabrication technologies". The Analyst 139 (6): 1303–26. March 2014. doi:10.1039/c3an01577g. PMID 24479125. Bibcode: 2014Ana...139.1303R.
54. ↑ 54.0 54.1 "Bio-microarray fabrication techniques—a review". Critical Reviews in Biotechnology 26 (4): 237–59. 2006-10-01. doi:10.1080/07388550600978358. PMID 17095434.
55. ↑ "Robotic spotting of cDNA and oligonucleotide microarrays". Trends in Biotechnology 23 (7): 374–9. July 2005. doi:10.1016/j.tibtech.2005.04.002. PMID 15978318.
56. ↑ "A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization". Genome Research 6 (7): 639–45. July 1996. doi:10.1101/gr.6.7.639. PMID 8796352.
57. ↑ "Expression monitoring by hybridization to high-density oligonucleotide arrays". Nature Biotechnology 14 (13): 1675–80. December 1996. doi:10.1038/nbt1296-1675. PMID 9634850.
58. ↑ "Summaries of Affymetrix GeneChip probe level data". Nucleic Acids Research 31 (4): 15e–15. February 2003. doi:10.1093/nar/gng015. PMID 12582260.
59. ↑ "Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH". Genes, Chromosomes & Cancer 44 (3): 305–19. November 2005. doi:10.1002/gcc.20243. PMID 16075461.
60. ↑ "Exponential scaling of single-cell RNA-seq in the past decade". Nature Protocols 13 (4): 599–604. April 2018. doi:10.1038/nprot.2017.149. PMID 29494575.
61. ↑ Tachibana, Chris (2015-08-18). "Transcriptomics today: Microarrays, RNA-seq, and more". Science 349 (6247): 544. doi:10.1126/science.opms.p1500095. Bibcode: 2015Sci...349..544T.
62. ↑ 62.0 62.1 "The transcriptional landscape of the yeast genome defined by RNA sequencing". Science 320 (5881): 1344–9. June 2008. doi:10.1126/science.1158441. PMID 18451266. Bibcode: 2008Sci...320.1344N.
63. ↑ "An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era". Genome Biology 15 (12): 523. December 2014. doi:10.1186/s13059-014-0523-y. PMID 25633159.
64. ↑ "Highly multiplexed subcellular RNA sequencing in situ". Science 343 (6177): 1360–3. March 2014. doi:10.1126/science.1250212. PMID 24578530. Bibcode: 2014Sci...343.1360L.
65. ↑ 65.0 65.1 "Next-generation DNA sequencing". Nature Biotechnology 26 (10): 1135–45. October 2008. doi:10.1038/nbt1486. PMID 18846087.
66. ↑ "IVT-seq reveals extreme bias in RNA sequencing". Genome Biology 15 (6): R86. June 2014. doi:10.1186/gb-2014-15-6-r86. PMID 24981968.
67. ↑ 67.0 67.1 "Systematic comparison of three methods for fragmentation of long-range PCR products for next generation sequencing". PLOS ONE 6 (11): e28240. 2011. doi:10.1371/journal.pone.0028240. PMID 22140562. Bibcode: 2011PLoSO...628240K.
68. ↑ "ClickSeq: Fragmentation-Free Next-Generation Sequencing via Click Ligation of Adaptors to Stochastically Terminated 3'-Azido cDNAs". Journal of Molecular Biology 427 (16): 2610–6. August 2015. doi:10.1016/j.jmb.2015.06.011. PMID 26116762.
69. ↑ "The impact of amplification on differential expression analyses by RNA-seq". Scientific Reports 6: 25533. May 2016. doi:10.1038/srep25533. PMID 27156886. Bibcode: 2016NatSR...625533P.
70. ↑ "Evaluation of commercially available RNA amplification kits for RNA sequencing using very low input amounts of total RNA". Journal of Biomolecular Techniques 26 (1): 4–18. April 2015. doi:10.7171/jbt.15-2601-001. PMID 25649271.
71. ↑ "Synthetic spike-in standards for RNA-seq experiments". Genome Research 21 (9): 1543–51. September 2011. doi:10.1101/gr.121095.111. PMID 21816910.
72. ↑ "Counting absolute numbers of molecules using unique molecular identifiers". Nature Methods 9 (1): 72–4. November 2011. doi:10.1038/nmeth.1778. PMID 22101854.
73. ↑ "mRNA-Seq whole-transcriptome analysis of a single cell". Nature Methods 6 (5): 377–82. May 2009. doi:10.1038/nmeth.1315. PMID 19349980.
74. ↑ "Quantitative single-cell RNA-seq with unique molecular identifiers". Nature Methods 11 (2): 163–6. February 2014. doi:10.1038/nmeth.2772. PMID 24363023.
75. ↑ "Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types". Science 343 (6172): 776–9. February 2014. doi:10.1126/science.1247651. PMID 24531970. Bibcode: 2014Sci...343..776J.
76. ↑ 76.0 76.1 "Comprehensive comparative analysis of strand-specific RNA sequencing methods". Nature Methods 7 (9): 709–15. September 2010. doi:10.1038/nmeth.1491. PMID 20711195.
77. ↑ "A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers". BMC Genomics 13: 341. July 2012. doi:10.1186/1471-2164-13-341. PMID 22827831.
78. ↑ 78.0 78.1 "Comparison of next-generation sequencing systems". Journal of Biomedicine & Biotechnology 2012: 251364. 2012. doi:10.1155/2012/251364. PMID 22829749.
79. ↑ "SRA". https://www.ncbi.nlm.nih.gov/sra. The NCBI Sequence Read Archive (SRA) was searched using “RNA-Seq[Strategy]” and one of "LS454[Platform]”, “Illumina[platform]”, "ABI Solid[Platform]”, "Ion Torrent[Platform]”, "PacBio SMRT"[Platform]” to report the number of RNA-Seq runs deposited for each platform.
80. ↑ "Performance comparison of benchtop high-throughput sequencing platforms". Nature Biotechnology 30 (5): 434–9. May 2012. doi:10.1038/nbt.2198. PMID 22522955.
81. ↑ "Coming of age: ten years of next-generation sequencing technologies". Nature Reviews Genetics 17 (6): 333–51. May 2016. doi:10.1038/nrg.2016.49. PMID 27184599.
82. ↑ "Highly parallel direct RNA sequencing on an array of nanopores" (in En). Nature Methods 15 (3): 201–206. March 2018. doi:10.1038/nmeth.4577. PMID 29334379.
83. ↑ "A complete bacterial genome assembled de novo using only nanopore sequencing data". Nature Methods 12 (8): 733–5. August 2015. doi:10.1038/nmeth.3444. PMID 26076426.
84. ↑ "Direct RNA sequencing". Nature 461 (7265): 814–8. October 2009. doi:10.1038/nature08390. PMID 19776739. Bibcode: 2009Natur.461..814O.
85. ↑ 85.0 85.1 "Calculating sample size estimates for RNA sequencing data". Journal of Computational Biology 20 (12): 970–8. December 2013. doi:10.1089/cmb.2012.0283. PMID 23961961.
86. ↑ 86.0 86.1 86.2 "A survey of best practices for RNA-seq data analysis". Genome Biology 17: 13. January 2016. doi:10.1186/s13059-016-0881-8. PMID 26813401.
87. ↑ 87.0 87.1 "Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data". Genome Biology 14 (9): R95. 2013. doi:10.1186/gb-2013-14-9-r95. PMID 24020486.
88. ↑ ENCODE Project Consortium; Aldred, Shelley F.; Collins, Patrick J.; Davis, Carrie A.; Doyle, Francis; Epstein, Charles B.; Frietze, Seth; Harrow, Jennifer et al. (September 2012). "An integrated encyclopedia of DNA elements in the human genome". Nature 489 (7414): 57–74. doi:10.1038/nature11247. PMID 22955616. Bibcode: 2012Natur.489...57T.
89. ↑ "ENCODE data at the ENCODE portal". Nucleic Acids Research 44 (D1): D726–32. January 2016. doi:10.1093/nar/gkv1160. PMID 26527727.
90. ↑ "ENCODE: Encyclopedia of DNA Elements". http://www.encodeproject.org.
91. ↑ 91.0 91.1 "Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology". Briefings in Bioinformatics 22 (6). Nov 2021. doi:10.1093/bib/bbab259. PMID 34329375.
92. ↑ 92.0 92.1 "limma powers differential expression analyses for RNA-sequencing and microarray studies". Nucleic Acids Research 43 (7): e47. April 2015. doi:10.1093/nar/gkv007. PMID 25605792.
93. ↑ 93.0 93.1 "edgeR: a Bioconductor package for differential expression analysis of digital gene expression data". Bioinformatics 26 (1): 139–40. January 2010. doi:10.1093/bioinformatics/btp616. PMID 19910308.
94. ↑ 94.0 94.1 "Orchestrating high-throughput genomic analysis with Bioconductor". Nature Methods 12 (2): 115–21. February 2015. doi:10.1038/nmeth.3252. PMID 25633503.
95. ↑ Smyth, G. K. (2005). "Limma: Linear Models for Microarray Data" (in en). Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Statistics for Biology and Health. Springer, New York, NY. pp. 397–420. doi:10.1007/0-387-29362-0_23. ISBN 9780387251462.
96. ↑ Steve., Russell (2008). Microarray Technology in Practice.. Meadows, Lisa A.. Burlington: Elsevier. ISBN 9780080919768. OCLC 437246554.
97. ↑ 97.0 97.1 "De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis". Nature Protocols 8 (8): 1494–512. August 2013. doi:10.1038/nprot.2013.084. PMID 23845962.
98. ↑ 98.0 98.1 "StringTie enables improved reconstruction of a transcriptome from RNA-seq reads" (in En). Nature Biotechnology 33 (3): 290–5. March 2015. doi:10.1038/nbt.3122. PMID 25690850.
99. ↑ "The Sequence Read Archive: explosive growth of sequencing data". Nucleic Acids Research 40 (Database issue): D54–6. January 2012. doi:10.1093/nar/gkr854. PMID 22009675.
100. ↑ 100.0 100.1 "Gene Expression Omnibus: NCBI gene expression and hybridization array data repository". Nucleic Acids Research 30 (1): 207–10. January 2002. doi:10.1093/nar/30.1.207. PMID 11752295.
101. ↑ Petrov, Anton; Shams, Soheil (2004-11-01). "Microarray Image Processing and Quality Control". Journal of VLSI Signal Processing Systems for Signal, Image and Video Technology 38 (3): 211–226. doi:10.1023/B:VLSI.0000042488.08307.ad.
102. ↑ Petrov, Anton; Shams, Soheil (2004). "Microarray Image Processing and Quality Control". The Journal of VLSI Signal Processing-Systems for Signal, Image, and Video Technology 38 (3): 211–226. doi:10.1023/B:VLSI.0000042488.08307.ad.
103. ↑ Kwon, Young Min; Ricke, Steven (2011). High-Throughput Next Generation Sequencing. Methods in Molecular Biology. 733. SpringerLink. doi:10.1007/978-1-61779-089-8. ISBN 978-1-61779-088-1.
104. ↑ "Sequence-specific error profile of Illumina sequencers". Nucleic Acids Research 39 (13): e90. July 2011. doi:10.1093/nar/gkr344. PMID 21576222.
105. ↑ "RNA-Seq: revelation of the messengers". Trends in Plant Science 18 (4): 175–9. April 2013. doi:10.1016/j.tplants.2013.02.001. PMID 23481128.
106. ↑ "FastQC: A Quality Control tool for High Throughput Sequence Data". Babraham Bioinformatics. 2010. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
107. ↑ "Rapid evaluation and quality control of next generation sequencing data with FaQCs". BMC Bioinformatics 15 (1): 366. November 2014. doi:10.1186/s12859-014-0366-2. PMID 25408143.
108. ↑ 108.0 108.1 108.2 "Differential analysis of gene regulation at transcript resolution with RNA-seq". Nature Biotechnology 31 (1): 46–53. January 2013. doi:10.1038/nbt.2450. PMID 23222703.
109. ↑ 109.0 109.1 "SOAPdenovo-Trans: de novo transcriptome assembly with short RNA-Seq reads". Bioinformatics 30 (12): 1660–6. June 2014. doi:10.1093/bioinformatics/btu077. PMID 24532719.
110. ↑ Siadjeu, Christian; Mayland-Quellhorst, Eike; Pande, Shruti; Laubinger, Sascha; Albach, Dirk C. (2021). "Transcriptome Sequence Reveals Candidate Genes Involving in the Post-Harvest Hardening of Trifoliate Yam Dioscorea dumetorum" (in en). Plants 10 (4): 787. doi:10.3390/plants10040787. PMID 33923758.
111. ↑ HTS Mappers. http://www.ebi.ac.uk/~nf/hts_mappers/
112. ↑ "Tools for mapping high-throughput sequencing data". Bioinformatics 28 (24): 3169–77. December 2012. doi:10.1093/bioinformatics/bts605. PMID 23060614.
113. ↑ "TopHat: discovering splice junctions with RNA-Seq". Bioinformatics 25 (9): 1105–11. May 2009. doi:10.1093/bioinformatics/btp120. PMID 19289445.
114. ↑ 114.0 114.1 "Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation". Nature Biotechnology 28 (5): 511–5. May 2010. doi:10.1038/nbt.1621. PMID 20436464.
115. ↑ "Assembly algorithms for next-generation sequencing data". Genomics 95 (6): 315–27. June 2010. doi:10.1016/j.ygeno.2010.03.001. PMID 20211242.
116. ↑ "Assessing De Novo transcriptome assembly metrics for consistency and utility". BMC Genomics 14: 465. July 2013. doi:10.1186/1471-2164-14-465. PMID 23837739.
117. ↑ "TransRate: reference-free quality assessment of de novo transcriptome assemblies". Genome Research 26 (8): 1134–44. August 2016. doi:10.1101/gr.196469.115. PMID 27252236.
118. ↑ "Evaluation of de novo transcriptome assemblies from RNA-Seq data". Genome Biology 15 (12): 553. December 2014. doi:10.1186/s13059-014-0553-5. PMID 25608678.
119. ↑ "Velvet: algorithms for de novo short read assembly using de Bruijn graphs". Genome Research 18 (5): 821–9. May 2008. doi:10.1101/gr.074492.107. PMID 18349386.
120. ↑ "Oases: robust de novo RNA-seq assembly across the dynamic range of expression levels". Bioinformatics 28 (8): 1086–92. April 2012. doi:10.1093/bioinformatics/bts094. PMID 22368243.
121. ↑ "De novo assembly and analysis of RNA-seq data". Nature Methods 7 (11): 909–12. November 2010. doi:10.1038/nmeth.1517. PMID 20935650.
122. ↑ 122.0 122.1 "Full-length transcriptome assembly from RNA-Seq data without a reference genome". Nature Biotechnology 29 (7): 644–52. May 2011. doi:10.1038/nbt.1883. PMID 21572440.
123. ↑ "Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs". Genome Research 14 (6): 1147–59. June 2004. doi:10.1101/gr.1917404. PMID 15140833.
124. ↑ "Genome sequencing in microfabricated high-density picolitre reactors". Nature 437 (7057): 376–80. September 2005. doi:10.1038/nature03959. PMID 16056220. Bibcode: 2005Natur.437..376M.
125. ↑ "Comparing de novo assemblers for 454 transcriptome data". BMC Genomics 11: 571. October 2010. doi:10.1186/1471-2164-11-571. PMID 20950480.
126. ↑ "SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing". Journal of Computational Biology 19 (5): 455–77. May 2012. doi:10.1089/cmb.2012.0021. PMID 22506599.
127. ↑ "RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome". BMC Bioinformatics 12: 323. August 2011. doi:10.1186/1471-2105-12-323. PMID 21816040.
128. ↑ Kovaka, Sam; Zimin, Aleksey V.; Pertea, Geo M.; Razaghi, Roham; Salzberg, Steven L.; Pertea, Mihaela (2019-07-08). "Transcriptome assembly from long-read RNA-seq alignments with StringTie2". bioRxiv: 694554. doi:10.1101/694554. https://www.biorxiv.org/content/10.1101/694554v1. Retrieved 27 August 2019.
129. ↑ "Visualization of omics data for systems biology" (in En). Nature Methods 7 (3 Suppl): S56–68. March 2010. doi:10.1038/nmeth.1436. PMID 20195258.
130. ↑ "HTSeq—a Python framework to work with high-throughput sequencing data". Bioinformatics 31 (2): 166–9. January 2015. doi:10.1093/bioinformatics/btu638. PMID 25260700.
131. ↑ "Near-optimal probabilistic RNA-seq quantification". Nature Biotechnology 34 (5): 525–7. May 2016. doi:10.1038/nbt.3519. PMID 27043002.
132. ↑ "The Sequence Alignment/Map format and SAMtools". Bioinformatics 25 (16): 2078–9. August 2009. doi:10.1093/bioinformatics/btp352. PMID 19505943.
133. ↑ "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2". Genome Biology 15 (12): 550. 2014. doi:10.1186/s13059-014-0550-8. PMID 25516281.
134. ↑ "Ballgown bridges the gap between transcriptome assembly and expression analysis" (in En). Nature Biotechnology 33 (3): 243–6. March 2015. doi:10.1038/nbt.3172. PMID 25748911.
135. ↑ "Design and validation issues in RNA-seq experiments". Briefings in Bioinformatics 12 (3): 280–7. May 2011. doi:10.1093/bib/bbr004. PMID 21498551.
136. ↑ "An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data". PLOS Computational Biology 5 (12): e1000598. December 2009. doi:10.1371/journal.pcbi.1000598. PMID 20011106. Bibcode: 2009PLSCB...5E0598R.
137. ↑ "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes". Genome Biology 3 (7): RESEARCH0034. June 2002. doi:10.1186/gb-2002-3-7-research0034. PMID 12184808.
138. ↑ "Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters". Science 322 (5909): 1845–8. December 2008. doi:10.1126/science.1162228. PMID 19056941. Bibcode: 2008Sci...322.1845C.
139. ↑ "Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing". PLOS Pathogens 6 (4): e1000834. April 2010. doi:10.1371/journal.ppat.1000834. PMID 20368969.
140. ↑ 140.0 140.1 "Identification and functional validation of a unique set of drought induced genes preferentially expressed in response to gradual water stress in peanut". Molecular Genetics and Genomics 281 (6): 591–605. June 2009. doi:10.1007/s00438-009-0432-z. PMID 19224247.
141. ↑ Tavassoly, Iman; Goldfarb, Joseph; Iyengar, Ravi (2018-10-04). "Systems biology primer: the basic methods and approaches" (in en). Essays in Biochemistry 62 (4): 487–500. doi:10.1042/EBC20180003. ISSN 0071-1365. PMID 30287586.
142. ↑ "RNA-Seq and human complex diseases: recent accomplishments and future perspectives". European Journal of Human Genetics 21 (2): 134–42. February 2013. doi:10.1038/ejhg.2012.129. PMID 22739340.
143. ↑ "Role of non-coding sequence variants in cancer". Nature Reviews Genetics 17 (2): 93–108. February 2016. doi:10.1038/nrg.2015.17. PMID 26781813.
144. ↑ "Transposable elements and the epigenetic regulation of the genome". Nature Reviews Genetics 8 (4): 272–85. April 2007. doi:10.1038/nrg2072. PMID 17363976.
145. ↑ "Single-cell technologies to study the immune system". Immunology 147 (2): 133–40. February 2016. doi:10.1111/imm.12553. PMID 26551575.
146. ↑ 146.0 146.1 "Translating RNA sequencing into clinical diagnostics: opportunities and challenges". Nature Reviews Genetics 17 (5): 257–71. May 2016. doi:10.1038/nrg.2016.10. PMID 26996076.
147. ↑ "Discovery of virulence factors of pathogenic bacteria". Current Opinion in Chemical Biology 12 (1): 93–101. February 2008. doi:10.1016/j.cbpa.2008.01.023. PMID 18284925. http://ntur.lib.ntu.edu.tw/bitstream/246246/219228/-1/26.pdf.
148. ↑ "Prediction of antibiotic resistance by gene expression profiles". Nature Communications 5: 5792. December 2014. doi:10.1038/ncomms6792. PMID 25517437. Bibcode: 2014NatCo...5.5792S.
149. ↑ "Dual RNA-seq of pathogen and host". Nature Reviews. Microbiology 10 (9): 618–30. September 2012. doi:10.1038/nrmicro2852. PMID 22890146. https://opus.bibliothek.uni-wuerzburg.de/files/11246/Dissertation_Westermann_Alexander.pdf.
150. ↑ "A review on computational systems biology of pathogen-host interactions". Frontiers in Microbiology 6: 235. 2015. doi:10.3389/fmicb.2015.00235. PMID 25914674.
151. ↑ 151.0 151.1 "Transcriptome analyses reveal genotype- and developmental stage-specific molecular responses to drought and salinity stresses in chickpea". Scientific Reports 6: 19228. January 2016. doi:10.1038/srep19228. PMID 26759178. Bibcode: 2016NatSR...619228G.
152. ↑ "Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns". Eukaryotic Cell 3 (2): 536–45. April 2004. doi:10.1128/EC.3.2.536-545.2004. PMID 15075282.
153. ↑ "The origin of malignant malaria". Proceedings of the National Academy of Sciences of the United States of America 106 (35): 14902–7. September 2009. doi:10.1073/pnas.0907740106. PMID 19666593. Bibcode: 2009PNAS..10614902R.
154. ↑ "Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance". Science 347 (6220): 431–5. January 2015. doi:10.1126/science.1260403. PMID 25502316. Bibcode: 2015Sci...347..431M.
155. ↑ 155.0 155.1 155.2 155.3 Page, Tessa M.; Lawley, Jonathan W. (2022). "The Next Generation Is Here: A Review of Transcriptomic Approaches in Marine Ecology". Frontiers in Marine Science 9. doi:10.3389/fmars.2022.757921. ISSN 2296-7745.
156. ↑ "Molecular mechanisms of metal hyperaccumulation in plants". The New Phytologist 181 (4): 759–76. March 2009. doi:10.1111/j.1469-8137.2008.02748.x. PMID 19192189. https://dipot.ulb.ac.be/dspace/bitstream/2013/58126/3/58126.pdf.
157. ↑ "RNA-Seq improves annotation of protein-coding genes in the cucumber genome". BMC Genomics 12: 540. November 2011. doi:10.1186/1471-2164-12-540. PMID 22047402.
158. ↑ "A transcriptome resource for the koala (Phascolarctos cinereus): insights into koala retrovirus transcription and sequence diversity". BMC Genomics 15 (1): 786. September 2014. doi:10.1186/1471-2164-15-786. PMID 25214207.
159. ↑ "A SNP resource for Douglas-fir: de novo transcriptome assembly and SNP detection and validation". BMC Genomics 14: 137. February 2013. doi:10.1186/1471-2164-14-137. PMID 23445355.
160. ↑ "De novo transcriptome assembly for the lobster Homarus americanus and characterization of differential gene expression across nervous system tissues". BMC Genomics 17: 63. January 2016. doi:10.1186/s12864-016-2373-3. PMID 26772543.
161. ↑ 161.0 161.1 "BiT age: A transcriptome-based aging clock near the theoretical limit of accuracy". Aging Cell 20 (3): e13320. 2020. doi:10.1111/acel.13320. PMID 33656257.
162. ↑ "Predicting age from the transcriptome of human dermal fibroblasts". Genome Biology 19 (1): 221. 2018. doi:10.1186/s13059-018-1599-6. PMID 30567591.
163. ↑ "Ribosomal RNA and translation". Annual Review of Biochemistry 60: 191–227. 1991. doi:10.1146/annurev.bi.60.070191.001203. PMID 1883196.
164. ↑ "Functional requirement of noncoding Y RNAs for human chromosomal DNA replication". Molecular and Cellular Biology 26 (18): 6993–7004. September 2006. doi:10.1128/MCB.01060-06. PMID 16943439.
165. ↑ "The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C". Science 311 (5758): 230–2. January 2006. doi:10.1126/science.1118265. PMID 16357227. Bibcode: 2006Sci...311..230K.
166. ↑ "Non-coding RNAs: hope or hype?". Trends in Genetics 21 (5): 289–97. May 2005. doi:10.1016/j.tig.2005.03.007. PMID 15851066.
167. ↑ "Non-coding RNAs in human disease". Nature Reviews Genetics 12 (12): 861–74. November 2011. doi:10.1038/nrg3074. PMID 22094949.
168. ↑ "Gene Expression Omnibus". https://www.ncbi.nlm.nih.gov/geo/.
169. ↑ 169.0 169.1 "Minimum information about a microarray experiment (MIAME)-toward standards for microarray data". Nature Genetics 29 (4): 365–71. December 2001. doi:10.1038/ng1201-365. PMID 11726920.
170. ↑ 170.0 170.1 "Minimum Information About a Microarray Experiment (MIAME)--successes, failures, challenges". TheScientificWorldJournal 9: 420–3. May 2009. doi:10.1100/tsw.2009.57. PMID 19484163.
171. ↑ "ArrayExpress update—simplifying data submissions". Nucleic Acids Research 43 (Database issue): D1113–6. January 2015. doi:10.1093/nar/gku1057. PMID 25361974.
172. ↑ "Expression Atlas update—an integrated database of gene and protein expression in humans, animals and plants". Nucleic Acids Research 44 (D1): D746–52. January 2016. doi:10.1093/nar/gkv1045. PMID 26481351.
173. ↑ "Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes". Advances in Bioinformatics 2008: 420747. 2008. doi:10.1155/2008/420747. PMID 19956698.
174. ↑ "BodyParts3D: 3D structure database for anatomical concepts". Nucleic Acids Research 37 (Database issue): D782–5. January 2009. doi:10.1093/nar/gkn613. PMID 18835852.
175. ↑ "NONCODE 2016: an informative and valuable data source of long non-coding RNAs". Nucleic Acids Research 44 (D1): D203–8. January 2016. doi:10.1093/nar/gkv1252. PMID 26586799.

### Notes

1. ↑ In molecular biology, hybridisation is a phenomenon in which single-stranded deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) molecules anneal to complementary DNA or RNA.
2. ↑ One picolitre is about 30 million times smaller than a drop of water.

## Further reading

* "Transcriptomics technologies". PLOS Computational Biology 13 (5): e1005457. May 2017. doi:10.1371/journal.pcbi.1005457. PMID 28545146. Bibcode: 2017PLSCB..13E5457L.
* Comparative Transcriptomics Analysis in Reference Module in Life Sciences
* Software used in transcriptomics:
* cufflinks
* kallisto
* tophat

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Transcriptomics technologies. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Biology:Transcriptomics_technologies&oldid=3506664"